SlideShare a Scribd company logo
National Leprosy Eradication
Programme- an Update
Presented by : Abdul
Samieh Deva
Moderator: Dr.
Syed Mubashir
Consultant; Deptt.
Of Dermatology
POSTGRADUATE DEPARTMENT OF DERMATOLOGY, STD
AND LEPROSY
National Leprosy Eradication
Programme
 Centrally sponsored health scheme
 the Ministry of Health and Family Welfare,
Govt. of India.
 headed by the Deputy Director of Health
Services (Leprosy )
 administrative control of the Directorate
General Health Services Govt. of India
 plans are formulated centrally, the
programme is implemented by the
States/UTs.
NLEP
Ministry of Health
and Family Welfare,
Govt. of India
WHO
ILEP
Other
NGOs
1955
• National Leprosy Control Programme
• Dapsone monotherapy
1983
• Launched NLEP and introduced MDT for treatment.
1991
• WHO declaration to eliminate leprosy at global level
by 2000.
1993 -
2000
• World Bank supported NLEP – I (552 crore/292 crore
WB)
2001 -
2004
• World Bank supported NLEP – II( 249.8 crore/. 166.35
Crore WB)
2005
• India achieved elimination of leprosy at National Level
in December’ 05. (0.95/10,000 Prevalence)
0 10 20 30 40 50 60
1981
Mar/01
Mar/11
57.6
3.74
0.69
PREVALENCE OF LEPROSY IN INDIA
Decentralization
Integration
with General
Health Care
System
Training
IEC
Early
diagnosis &
prompt MDT
DPMR
Monitoring
and
Evaluation
STRATEGY
OF NLEP
SELF CARE ADVICE
ADVICE TO RCS CASES
MONITORING
REACTION
DISABILITY
MANAGE REACTIONS OR
REFER
IDENTIFY PATIENT FOR RCS
AND NEEDING FOOT-WEAR
ADVICE TO RCS CASES
SELF CARE ADVICE
DIFFICULT LEPRA
REACTIONS
COMPLICATED ULCERS
EYE PROBLEMS
RCS CASES
PERSONS NEEDING
FOOTWEAR
MANAGE ULCERS/
LEPRA REACTIONS
REFER DIFFICULT
ULCERS TO RCS CENTRE
MANAGEMENT OF
LEPRA REACTIONS
SUPPLY OF FOOT-
WEAR
RCS
SUPPLY OF fw
to DN
Sub
centre
PHC
DISTRICT
HOSPITAL
DISTRICT
NUCLEUS
NEED FOR A REFERRAL SYSTEM
 2001-2002: Leprosy
services integrated into
GHS
 The strength of erstwhile
vertical leprosy staff was
reduced to 25% by March 2004.
The staff was kept at CHC/PHC
level and under DLO in District
nucleus for support of
peripheral staff.
 GH Service Personnel are
trained to clinically diagnose
cases using WHO case
definition.
• Diagnosis of doubtful
cases.
• Cases with reactions
under treatment with
steroids if there is no
response after 4 weeks.
• Complications with other
system involvement
including eye
involvement.
• Reconstructive surgery
(RCS).
GUIDELINES FOR DRAWING UP STATEWISE REFERRAL SYSTEM
 The Dermatologist/ Medical Specialist-main referral
point in district hospital
 Diagnosed patients should be referred back to PHC for
MDT or they may be shortly managed there for
complications.
 The states have to draw up suitable referral card from
PHC to the Referral centre and back
 The identified Medical Specialist/ Dermatologist will
preferably be given a specialized training for diagnosis of
doubtful leprosy cases and management of complicated
cases. The ILEP organizations have agreed to provide
such training in 122 apex leprosy institutions in the
country.
Incentives to ASHA workers in NLEP
• The scheme will be initiated in five States viz.
Chhattisgarh, Jharkhand, Bihar, West Bengal
and Uttar Pradesh
• Half day training/sensitization for ASHA in
leprosy
• ASHA will refer suspect cases to health facility
• Diagnosis by MO
• ASHA will monitor daily drug intake
• An amount of Rs. 300/- and Rs. 500/- will be
paid to ASHA per PB and MB case respectively.
Major initiatives under NLEP
 New case detection rate is given more focus
over prevalence
 Treatment completion rate needs to be
calculated by states on yearly basis
 More stress on DPMR services
 Involvement of ASHAs
 Above types of services to 612 leprosy colonies
on fortnightly/weekly basis through NGOs or
paramedics.
 Intensive IEC campaign on a theme- “Towards
Leprosy Free India”
DPMR
o Implementation of DPMR and reporting its outcome
o Integration of DPMR services via NRHM
o Develop a referral system
o Tertiary institutions- CLTRI Chingelpettu and
RLTRIs/ICMR Institute JALMA, Agra/ILEP supported
Leprosy Hospitals/All PMR institutes and departments of
medical colleges
o Other support centres: ortho/plastic surgery departments
of med. colleges; NGOs; All National Institutes under
Ministry of Social Justice and Empowerment;
Contractual surgeons skilled in RCS and Rehabilitation
Programmes
DPMR SERVICES
o Dressing materials, supportive medicines and
ulcer kits for ulcer patients individually/or in
colonies
o MCR footwear for insensitive feet
o RCS
o Rs 5000/=as incentive to leprosy affected BPL
person for undergoing reconstructive surgery(At
discharge: Rs 3000/ At 1 month follow up: Rs
1000/ At 3rd month : Rs 1000)
o Rs 5000/= to Govt. institution/PMR centre per
RCS performed
Correction of claw
hand and Opponens
plasty
Wrist drop correction
Stabilization
procedures
Tissue reconstruction
procedures such as
contracture release
and flap cover
Hand RCS
under NLEP
Foot drop correction claw toe correction
Soft tissue
reconstruction of the
sole
Arthrodesis
Foot RCS
under NLEP
Lagophthalamos
correction
Reconstruction
of collapsed
nose
Indicators used to monitor
progress in NLEP
• New case detection rate
• Treatment completion rate
Core indicators
• Disability proportion
• MB Case proportion
• Child proportion
Epidemiological
indicators
• Proportion of defaulters
• Number of relapses reported during the year
• Proportion of new cases correctly diagnosed
• Proportion of cases with new disabilities
Quality of
service
indicators
Annual New Case Detection Rate
ANCDR = No. of new cases detected during the year × 100
Population as on 31st March
ANCDR will be the main indicator for NLEP
ANCDR to be assessed on 31st March each year. New cases
detected from April of previous calendar year to March of current
year are included.
The definition of new case – “A case with signs of leprosy, who have never received
treatment before” should be strictly followed.
Quaterly assessment of NCDR
• Quarterly assessment of NCDR at
State/District/Block level will better help in
understanding of the leprosy status in
different areas, on which action can be
initiated in time.
• Both the actual number of new cases
detected during the year and ANCDR are
important for assessment for leprosy
situation.
Treatment Completion Rate
o It is to be ascertained for:
o PB and MB cases treated
o PB Male/PB Female and MB Male/Female treated
o Rural/Urban areas
o
PB TCR = No. of new PB cases who completed MDT in 9 months × 100
No. of new cases who started MDT
Example: For reporting year 2006-2007
PB- All new cases detected and started treatment between April 2005-
March 2006 are taken
MB- All new cases detected and started treatment between April 2004-
March 2005 are taken
USES OF TCR
• TCR is a proxy indicator for cure rate.
• It is indicator for how well the leprosy
patients are being served by the health
services
Disability proportion
It is the percentage of people with disability among the
new leprosy cases detected during the reporting year.
DG I proportion = Number of new cases with disability grade I × 100
Total number of new cases detected
Similarly Disability grade II proportion is also calculated.
Interpretation of Disability Grade
The grade II disability proportion will be higher at the
beginning of the programme activities.
It would also rise when unserved leprosy endemic
pockets are taken up for intensive campaign.
A high percentage of grade II disabilities is a
sign of late case detection.
Another reason may be a diminishing
awareness and poor skill among health
workers.
MB Proportion
MB Proportion = Number of MB cases among newly detected cases × 100
Total number of new cases detected
Uses:
It is essential for knowing about the likelihood of leprosy
transmission in community and for calculating drug
requirements.
Interpretation of
MB Proportion
It is increased by
• the start of leprosy
control programme
• wide definition of
MB cases
• A shift from active
to passive case
detection
It is decreased by
• A shift from initial phase
to intermediate leprosy
control
• Narrow definition of an
MB case
• Active case detection
including school survey
(This will detect cases at
PB stage)
Child proportion
Child proportion = No. of children among new cases detected × 100
Total no. of new cases detected
 Age < 15 years
 A high child proportion may be a sign of recent and active
transmission. It is also valuable in calculating drug requirements.
 CP is low at the beginning of programme. Then once an
accumulated backlog of adult cases is dealt with CP rises and
stabilizes at a higher rate. The CP towards the end would
decrease but that is a slow process.
What influences CP?
CP is increased by
 School surveys
 Middle of a programme
CP is decreased by
 if previously untouched
leprosy endemic pockets
are taken up for work.
 due to increased
immunity of the
population on account of
BCG vaccination and to
other mycobacterial
infections.
Proportion of female cases
Proportion of female cases = No. of female cases detected in a year × 100
New cases detected
 It is an indicator of adequate access of
women to health services
 Normally a ratio of 2 males to 1 female is
seen
Prevalence rate
Prevalence rate = No. of balance new cases under treatment as on 31st March ×10,000
Population as on 31st March
 It is calculated as a point prevalence as on 31st
March.
 Not a good indicator after elimination has been
achieved
 Proposed to be used till all states achieve elimination.
Proportion of defaulters
Proportion of defaulters = no. of cases defaulted from treatment × 100
No. of cases started on treatment
Defaulter is a leprosy patient who does not
complete the treatment within 9 months for
PB or 18 months of MB treatment
Actions suggested to reduce default
o Cases must be followed regularly instead
of waiting for 9 or 18 months.
o Reasons for default should be recorded by
MOs for each patient routinely instead of
tracing them at the end which may be
difficult
o Corrective actions should be taken by
PHCs/UHCs if possible.
o Services of ASHAs under NRHM be
suitably utilized.
Number of relapses
 A relapse case of leprosy is defined as
the re-occurrence of the disease at any
time after completion of the treatment.
 Actions required:
o The relapse is to be suspected at primary level
o It is to be confirmed by a dermatologist at secondary
level
o DLO will have to maintain a record of relapse cases and
report it to State Leprosy Office. SLO will analyse data
from the districts and if any area is showing high relapse
Proportion of New cases correctly diagnosed
• The correction of diagnosis is to be
assessed by the District Nucleus
• A sample of new cases that have been
diagnosed at primary level are to be
validated within 3 months of diagnosis
•
Proportion of new cases = No. of correctly diagnosed × 100
correctly diagnosed No. of New cases validated
Actions required: DLO has to identify the persons involved in
wrong diagnosis and arrange for their additional training and
skill development.
Proportion of cases with new disabilities
Proportion of cases with new disabilities = No. of cases developing new disability × 100
No. of cases put on MDT during the year
 The indicator gives information on quality of services at PHC/UHC level.
 The DLO is to compile the record of this information for the district
PHC/urban area wise and work out the indicator annually
Behaviour change communication
• An intensive IEC campaign towards
“Leprosy free India”
• Centre to formulate core messages, mass
media and advocacy events besides
overall leadership
• States to base their strategies on core
framework
• A dist level ‘Advisory cum monitoring
committee’ will take help from all
stakeholders
BCC (contd.)
• The MO block will be the coordinator of
IEC activities in the block
• Target groups- Community, LAPs,
GHCS, NGOs, CBOs, Disabled Peoples
Organizations.
BCC
activities
Village
level
meetings
Health
camps
Advocacy
meetings
Community
feasts
Media
sensitizati
on
Posters
News ads
FGDs
Prevalence 0.16/10,000 population 0.68
MB proportion 76.57% 49
MB Female 18.86% 37
Child MB proportion 1.71% 9.7
Grade I disability 1.71% 3.78
Grade II disability 2.29% -
RCS 0 %
Child case rate 0.02 / 100,000 population 1
New disability case rate 0.31/million population -
% of country’s case load 0.25 -
% of country’s population 1.04 -
No. of districts with gr II
disability >2/million
population 2
Thank
You

More Related Content

What's hot

What's hot (20)

krithiga nlep
 krithiga nlep krithiga nlep
krithiga nlep
 
Tb programme
Tb programmeTb programme
Tb programme
 
Indian public health standards
Indian public health standardsIndian public health standards
Indian public health standards
 
National Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran VenkataramanNational Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran Venkataraman
 
RNTCP
RNTCPRNTCP
RNTCP
 
National Leprosy Eradication Programme
National Leprosy Eradication ProgrammeNational Leprosy Eradication Programme
National Leprosy Eradication Programme
 
Npcdcs
NpcdcsNpcdcs
Npcdcs
 
NATIONAL AIDS CONTROL PROGRAMME (NACP)
NATIONAL AIDS CONTROL PROGRAMME  (NACP)NATIONAL AIDS CONTROL PROGRAMME  (NACP)
NATIONAL AIDS CONTROL PROGRAMME (NACP)
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
 
Tuberculosis control in india
Tuberculosis control in indiaTuberculosis control in india
Tuberculosis control in india
 
National population policy 2002
National population policy 2002National population policy 2002
National population policy 2002
 
National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
 
Tb control in india
Tb control in indiaTb control in india
Tb control in india
 
RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
 
NITI Aayog and Planning Commission
NITI Aayog and Planning CommissionNITI Aayog and Planning Commission
NITI Aayog and Planning Commission
 
national vector born disear
national vector born disear national vector born disear
national vector born disear
 
National std control programme 11
National std control programme 11National std control programme 11
National std control programme 11
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
 
National health policy 2017
National health policy 2017National health policy 2017
National health policy 2017
 
ASHA
ASHAASHA
ASHA
 

Similar to National Leprosy Eradication Programme.pptx

nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
ssuserd6cc4b
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
Isha Porwal
 
National Leprosy Eradication Program(NLEP)-1.pptx
National Leprosy Eradication Program(NLEP)-1.pptxNational Leprosy Eradication Program(NLEP)-1.pptx
National Leprosy Eradication Program(NLEP)-1.pptx
Lavanya122320
 

Similar to National Leprosy Eradication Programme.pptx (20)

RNTCP ARPIT.pptx
RNTCP ARPIT.pptxRNTCP ARPIT.pptx
RNTCP ARPIT.pptx
 
Leprosy nlep & currents trends
Leprosy nlep & currents trendsLeprosy nlep & currents trends
Leprosy nlep & currents trends
 
RNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.pptRNTCP-Basic Presantation.ppt
RNTCP-Basic Presantation.ppt
 
Newer antifungals.pptx
Newer antifungals.pptxNewer antifungals.pptx
Newer antifungals.pptx
 
Deepak rntcp
Deepak rntcpDeepak rntcp
Deepak rntcp
 
NLEP (Sheetal Sharma)
NLEP (Sheetal Sharma) NLEP (Sheetal Sharma)
NLEP (Sheetal Sharma)
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
 
National leprosy eradication programme
National leprosy eradication programmeNational leprosy eradication programme
National leprosy eradication programme
 
A PRESENTATION ON- NATIONAL LEPROSY CONTROL PROGRAM AYANSH SINGH.pptx
A PRESENTATION ON- NATIONAL LEPROSY CONTROL PROGRAM AYANSH SINGH.pptxA PRESENTATION ON- NATIONAL LEPROSY CONTROL PROGRAM AYANSH SINGH.pptx
A PRESENTATION ON- NATIONAL LEPROSY CONTROL PROGRAM AYANSH SINGH.pptx
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
 
Rntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tbRntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tb
 
RNTCP
RNTCPRNTCP
RNTCP
 
STD contol programme.pptx
STD contol programme.pptxSTD contol programme.pptx
STD contol programme.pptx
 
RNTCP-ASHUTOSH.pdf
RNTCP-ASHUTOSH.pdfRNTCP-ASHUTOSH.pdf
RNTCP-ASHUTOSH.pdf
 
2015 indicator reference guide priority pop prevention services
2015 indicator reference guide   priority pop prevention services2015 indicator reference guide   priority pop prevention services
2015 indicator reference guide priority pop prevention services
 
Leprosey Represented by NIRJESH KUMAR
Leprosey Represented by NIRJESH KUMARLeprosey Represented by NIRJESH KUMAR
Leprosey Represented by NIRJESH KUMAR
 
National Leprosy Eradication Program(NLEP)-1.pptx
National Leprosy Eradication Program(NLEP)-1.pptxNational Leprosy Eradication Program(NLEP)-1.pptx
National Leprosy Eradication Program(NLEP)-1.pptx
 
World tb day 2015
World tb day 2015World tb day 2015
World tb day 2015
 
Tuberculosis National Health Program in Nepal
Tuberculosis National Health Program  in Nepal Tuberculosis National Health Program  in Nepal
Tuberculosis National Health Program in Nepal
 

More from Neyaz Ahmad (7)

Pathology of Acute Inflammation
Pathology of Acute InflammationPathology of Acute Inflammation
Pathology of Acute Inflammation
 
Leprosy - Introduction and Epidemiology
Leprosy - Introduction and EpidemiologyLeprosy - Introduction and Epidemiology
Leprosy - Introduction and Epidemiology
 
Risk Factors of Hypertension
Risk Factors of HypertensionRisk Factors of Hypertension
Risk Factors of Hypertension
 
National Population Policy
National Population PolicyNational Population Policy
National Population Policy
 
PREVENTION AND CONTROL OF IODINE DEFICIENCY DISORDERS & NIDDCP
PREVENTION AND CONTROL OF IODINE DEFICIENCY DISORDERS & NIDDCPPREVENTION AND CONTROL OF IODINE DEFICIENCY DISORDERS & NIDDCP
PREVENTION AND CONTROL OF IODINE DEFICIENCY DISORDERS & NIDDCP
 
Delivery System of Family Welfare Program in India
Delivery System of Family Welfare Program in IndiaDelivery System of Family Welfare Program in India
Delivery System of Family Welfare Program in India
 
Blood Physiology
Blood PhysiologyBlood Physiology
Blood Physiology
 

Recently uploaded

Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdfDr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam
 
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
larisashrestha558
 

Recently uploaded (20)

Heidi Livengood Resume Senior Technical Recruiter / HR Generalist
Heidi Livengood Resume Senior Technical Recruiter / HR GeneralistHeidi Livengood Resume Senior Technical Recruiter / HR Generalist
Heidi Livengood Resume Senior Technical Recruiter / HR Generalist
 
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
 
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
 
DIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptxDIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptx
 
Operating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdfOperating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdf
 
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
 
0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdf0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdf
 
135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of Engineering135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of Engineering
 
Biography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdfBiography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdf
 
133. Reviewer Certificate in Advances in Research
133. Reviewer Certificate in Advances in Research133. Reviewer Certificate in Advances in Research
133. Reviewer Certificate in Advances in Research
 
Widal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid feverWidal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid fever
 
134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer Science134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer Science
 
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
 
132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical Sciences132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical Sciences
 
Day care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring childrenDay care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring children
 
129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]
 
D.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdfD.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdf
 
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdfDr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
 
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
皇冠体育- 皇冠体育官方网站- CROWN SPORTS| 立即访问【ac123.net】
 
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
 

National Leprosy Eradication Programme.pptx

  • 1. National Leprosy Eradication Programme- an Update Presented by : Abdul Samieh Deva Moderator: Dr. Syed Mubashir Consultant; Deptt. Of Dermatology POSTGRADUATE DEPARTMENT OF DERMATOLOGY, STD AND LEPROSY
  • 2. National Leprosy Eradication Programme  Centrally sponsored health scheme  the Ministry of Health and Family Welfare, Govt. of India.  headed by the Deputy Director of Health Services (Leprosy )  administrative control of the Directorate General Health Services Govt. of India  plans are formulated centrally, the programme is implemented by the States/UTs.
  • 3. NLEP Ministry of Health and Family Welfare, Govt. of India WHO ILEP Other NGOs
  • 4. 1955 • National Leprosy Control Programme • Dapsone monotherapy 1983 • Launched NLEP and introduced MDT for treatment. 1991 • WHO declaration to eliminate leprosy at global level by 2000. 1993 - 2000 • World Bank supported NLEP – I (552 crore/292 crore WB) 2001 - 2004 • World Bank supported NLEP – II( 249.8 crore/. 166.35 Crore WB) 2005 • India achieved elimination of leprosy at National Level in December’ 05. (0.95/10,000 Prevalence)
  • 5. 0 10 20 30 40 50 60 1981 Mar/01 Mar/11 57.6 3.74 0.69 PREVALENCE OF LEPROSY IN INDIA
  • 6. Decentralization Integration with General Health Care System Training IEC Early diagnosis & prompt MDT DPMR Monitoring and Evaluation STRATEGY OF NLEP
  • 7.
  • 8. SELF CARE ADVICE ADVICE TO RCS CASES MONITORING REACTION DISABILITY MANAGE REACTIONS OR REFER IDENTIFY PATIENT FOR RCS AND NEEDING FOOT-WEAR ADVICE TO RCS CASES SELF CARE ADVICE DIFFICULT LEPRA REACTIONS COMPLICATED ULCERS EYE PROBLEMS RCS CASES PERSONS NEEDING FOOTWEAR MANAGE ULCERS/ LEPRA REACTIONS REFER DIFFICULT ULCERS TO RCS CENTRE MANAGEMENT OF LEPRA REACTIONS SUPPLY OF FOOT- WEAR RCS SUPPLY OF fw to DN Sub centre PHC DISTRICT HOSPITAL DISTRICT NUCLEUS
  • 9. NEED FOR A REFERRAL SYSTEM  2001-2002: Leprosy services integrated into GHS  The strength of erstwhile vertical leprosy staff was reduced to 25% by March 2004. The staff was kept at CHC/PHC level and under DLO in District nucleus for support of peripheral staff.  GH Service Personnel are trained to clinically diagnose cases using WHO case definition. • Diagnosis of doubtful cases. • Cases with reactions under treatment with steroids if there is no response after 4 weeks. • Complications with other system involvement including eye involvement. • Reconstructive surgery (RCS).
  • 10. GUIDELINES FOR DRAWING UP STATEWISE REFERRAL SYSTEM  The Dermatologist/ Medical Specialist-main referral point in district hospital  Diagnosed patients should be referred back to PHC for MDT or they may be shortly managed there for complications.  The states have to draw up suitable referral card from PHC to the Referral centre and back  The identified Medical Specialist/ Dermatologist will preferably be given a specialized training for diagnosis of doubtful leprosy cases and management of complicated cases. The ILEP organizations have agreed to provide such training in 122 apex leprosy institutions in the country.
  • 11. Incentives to ASHA workers in NLEP • The scheme will be initiated in five States viz. Chhattisgarh, Jharkhand, Bihar, West Bengal and Uttar Pradesh • Half day training/sensitization for ASHA in leprosy • ASHA will refer suspect cases to health facility • Diagnosis by MO • ASHA will monitor daily drug intake • An amount of Rs. 300/- and Rs. 500/- will be paid to ASHA per PB and MB case respectively.
  • 12. Major initiatives under NLEP  New case detection rate is given more focus over prevalence  Treatment completion rate needs to be calculated by states on yearly basis  More stress on DPMR services  Involvement of ASHAs  Above types of services to 612 leprosy colonies on fortnightly/weekly basis through NGOs or paramedics.  Intensive IEC campaign on a theme- “Towards Leprosy Free India”
  • 13. DPMR o Implementation of DPMR and reporting its outcome o Integration of DPMR services via NRHM o Develop a referral system o Tertiary institutions- CLTRI Chingelpettu and RLTRIs/ICMR Institute JALMA, Agra/ILEP supported Leprosy Hospitals/All PMR institutes and departments of medical colleges o Other support centres: ortho/plastic surgery departments of med. colleges; NGOs; All National Institutes under Ministry of Social Justice and Empowerment; Contractual surgeons skilled in RCS and Rehabilitation Programmes
  • 14. DPMR SERVICES o Dressing materials, supportive medicines and ulcer kits for ulcer patients individually/or in colonies o MCR footwear for insensitive feet o RCS o Rs 5000/=as incentive to leprosy affected BPL person for undergoing reconstructive surgery(At discharge: Rs 3000/ At 1 month follow up: Rs 1000/ At 3rd month : Rs 1000) o Rs 5000/= to Govt. institution/PMR centre per RCS performed
  • 15. Correction of claw hand and Opponens plasty Wrist drop correction Stabilization procedures Tissue reconstruction procedures such as contracture release and flap cover Hand RCS under NLEP
  • 16. Foot drop correction claw toe correction Soft tissue reconstruction of the sole Arthrodesis Foot RCS under NLEP
  • 18. Indicators used to monitor progress in NLEP
  • 19. • New case detection rate • Treatment completion rate Core indicators • Disability proportion • MB Case proportion • Child proportion Epidemiological indicators • Proportion of defaulters • Number of relapses reported during the year • Proportion of new cases correctly diagnosed • Proportion of cases with new disabilities Quality of service indicators
  • 20. Annual New Case Detection Rate ANCDR = No. of new cases detected during the year × 100 Population as on 31st March ANCDR will be the main indicator for NLEP ANCDR to be assessed on 31st March each year. New cases detected from April of previous calendar year to March of current year are included. The definition of new case – “A case with signs of leprosy, who have never received treatment before” should be strictly followed.
  • 21. Quaterly assessment of NCDR • Quarterly assessment of NCDR at State/District/Block level will better help in understanding of the leprosy status in different areas, on which action can be initiated in time. • Both the actual number of new cases detected during the year and ANCDR are important for assessment for leprosy situation.
  • 22. Treatment Completion Rate o It is to be ascertained for: o PB and MB cases treated o PB Male/PB Female and MB Male/Female treated o Rural/Urban areas o PB TCR = No. of new PB cases who completed MDT in 9 months × 100 No. of new cases who started MDT Example: For reporting year 2006-2007 PB- All new cases detected and started treatment between April 2005- March 2006 are taken MB- All new cases detected and started treatment between April 2004- March 2005 are taken
  • 23. USES OF TCR • TCR is a proxy indicator for cure rate. • It is indicator for how well the leprosy patients are being served by the health services
  • 24. Disability proportion It is the percentage of people with disability among the new leprosy cases detected during the reporting year. DG I proportion = Number of new cases with disability grade I × 100 Total number of new cases detected Similarly Disability grade II proportion is also calculated.
  • 25. Interpretation of Disability Grade The grade II disability proportion will be higher at the beginning of the programme activities. It would also rise when unserved leprosy endemic pockets are taken up for intensive campaign. A high percentage of grade II disabilities is a sign of late case detection. Another reason may be a diminishing awareness and poor skill among health workers.
  • 26. MB Proportion MB Proportion = Number of MB cases among newly detected cases × 100 Total number of new cases detected Uses: It is essential for knowing about the likelihood of leprosy transmission in community and for calculating drug requirements.
  • 27. Interpretation of MB Proportion It is increased by • the start of leprosy control programme • wide definition of MB cases • A shift from active to passive case detection It is decreased by • A shift from initial phase to intermediate leprosy control • Narrow definition of an MB case • Active case detection including school survey (This will detect cases at PB stage)
  • 28. Child proportion Child proportion = No. of children among new cases detected × 100 Total no. of new cases detected  Age < 15 years  A high child proportion may be a sign of recent and active transmission. It is also valuable in calculating drug requirements.  CP is low at the beginning of programme. Then once an accumulated backlog of adult cases is dealt with CP rises and stabilizes at a higher rate. The CP towards the end would decrease but that is a slow process.
  • 29. What influences CP? CP is increased by  School surveys  Middle of a programme CP is decreased by  if previously untouched leprosy endemic pockets are taken up for work.  due to increased immunity of the population on account of BCG vaccination and to other mycobacterial infections.
  • 30. Proportion of female cases Proportion of female cases = No. of female cases detected in a year × 100 New cases detected  It is an indicator of adequate access of women to health services  Normally a ratio of 2 males to 1 female is seen
  • 31. Prevalence rate Prevalence rate = No. of balance new cases under treatment as on 31st March ×10,000 Population as on 31st March  It is calculated as a point prevalence as on 31st March.  Not a good indicator after elimination has been achieved  Proposed to be used till all states achieve elimination.
  • 32. Proportion of defaulters Proportion of defaulters = no. of cases defaulted from treatment × 100 No. of cases started on treatment Defaulter is a leprosy patient who does not complete the treatment within 9 months for PB or 18 months of MB treatment
  • 33. Actions suggested to reduce default o Cases must be followed regularly instead of waiting for 9 or 18 months. o Reasons for default should be recorded by MOs for each patient routinely instead of tracing them at the end which may be difficult o Corrective actions should be taken by PHCs/UHCs if possible. o Services of ASHAs under NRHM be suitably utilized.
  • 34. Number of relapses  A relapse case of leprosy is defined as the re-occurrence of the disease at any time after completion of the treatment.  Actions required: o The relapse is to be suspected at primary level o It is to be confirmed by a dermatologist at secondary level o DLO will have to maintain a record of relapse cases and report it to State Leprosy Office. SLO will analyse data from the districts and if any area is showing high relapse
  • 35. Proportion of New cases correctly diagnosed • The correction of diagnosis is to be assessed by the District Nucleus • A sample of new cases that have been diagnosed at primary level are to be validated within 3 months of diagnosis • Proportion of new cases = No. of correctly diagnosed × 100 correctly diagnosed No. of New cases validated Actions required: DLO has to identify the persons involved in wrong diagnosis and arrange for their additional training and skill development.
  • 36. Proportion of cases with new disabilities Proportion of cases with new disabilities = No. of cases developing new disability × 100 No. of cases put on MDT during the year  The indicator gives information on quality of services at PHC/UHC level.  The DLO is to compile the record of this information for the district PHC/urban area wise and work out the indicator annually
  • 37. Behaviour change communication • An intensive IEC campaign towards “Leprosy free India” • Centre to formulate core messages, mass media and advocacy events besides overall leadership • States to base their strategies on core framework • A dist level ‘Advisory cum monitoring committee’ will take help from all stakeholders
  • 38. BCC (contd.) • The MO block will be the coordinator of IEC activities in the block • Target groups- Community, LAPs, GHCS, NGOs, CBOs, Disabled Peoples Organizations.
  • 40.
  • 41.
  • 42.
  • 43. Prevalence 0.16/10,000 population 0.68 MB proportion 76.57% 49 MB Female 18.86% 37 Child MB proportion 1.71% 9.7 Grade I disability 1.71% 3.78 Grade II disability 2.29% - RCS 0 % Child case rate 0.02 / 100,000 population 1 New disability case rate 0.31/million population - % of country’s case load 0.25 - % of country’s population 1.04 - No. of districts with gr II disability >2/million population 2